Clinical trial Recruiting at 69 sites Observational Ages 18 to 80

Liver transplantation outcomes for patients with severe liver failure

Official title: Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure (ACLF): iNdications and outComEs

Run by European Foundation for Study of Chronic Liver Failure · NCT04613921 · Data updated 2026-11-12

This study is testing how well liver transplants work for people with severe liver failure compared to those with advanced cirrhosis to see which group has better survival rates and quality of life after the transplant.

More Liver Transplant trials

Quick facts

Study typeObservational
Ages18 Years to 80 Years
SexAll
Enrollment3000 (estimated)
SponsorEuropean Foundation for Study of Chronic Liver Failure
Academic / other
Locations106 sites (Los Angeles, California and 105 other locations)
StatusRecruiting
StartedJuly 8, 2021
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedOctober 20, 2025
Trial IDNCT04613921 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older with liver cirrhosis who have been hospitalized for acute decompensation and are either listed for transplantation with ACLF-2 or 3 or assessed for listing but not listed.

Probably not a fit

Patients with liver cirrhosis who do not have ACLF or those who are not hospitalized for acute decompensation may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to compare the one-year graft and patient survival rates after liver transplantation in patients with severe acute-on-chronic liver failure (ACLF-2 or 3) against those with decompensated cirrhosis without ACLF. It will also evaluate the transplant-free survival of patients with ACLF who are not listed for transplantation. Secondary objectives include assessing the reasons for listing decisions, outcomes of patients on the waiting list, and developing a prognostic model to predict mortality on the waiting list. The study will explore independent predictive factors of death after transplantation and compare post-transplant survival rates and quality of life between the two groups.

Why it matters

Potential benefit: If successful, this study could improve the understanding of liver transplantation outcomes for patients with severe liver failure, potentially leading to better patient selection and management strategies.

How similar studies have gone: While there have been studies on liver transplantation in patients with cirrhosis, this specific focus on ACLF-2 or 3 is less common, making this approach relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 1\. Male or female subject ≥18 years of age.

  2\. Subjects with diagnosis of liver cirrhosis (based on clinical, laboratory, endoscopic, and ultrasonographic features or on histology).

  3\. Subjects who have been hospitalized for acute decompensation of liver cirrhosis and referred to the transplant team:
* Group 1: patients listed for liver transplantation with ACLF-2 or 3 at the time of listing or developing ACLF 2-3 while on the waiting list.
* Group 2: patients listed for liver transplantation with decompensated cirrhosis without ACLF-2 or 3 and poor liver function (MELD\>20) at the time of listing.
* Group 3: patients having ACLF-2 or 3, are assessed for inclusion in the waiting list, but are finally not listed for liver transplantation.

  4\. Patients (or trusted person, family member or close relation if the patient is unable to express consent) who have been informed and signed their informed consent Inclusion criteria

Exclusion Criteria:

\-

Where it's running

  • Cedars-Sinai Comprehensive Transplant Center
    Los Angeles, California, United States
    Recruiting
  • University of Colorado
    Aurora, Colorado, United States
    Recruiting
  • Piedmont Healthcare
    Atlanta, Georgia, United States
    Recruiting
  • The University of Chicago Medicine
    Chicago, Illinois, United States
    Recruiting
  • University of Maryland School of Medicine
    Baltimore, Maryland, United States
    Recruiting
  • Weill Cornell Medicine
    New York, New York, United States
    Recruiting
Show 44 more locations
  • Icahn School of Medicine at Mount Sinai
    New York, New York, United States
    Recruiting
  • Cleveland Clinic
    Cleveland, Ohio, United States
    Recruiting
  • Baylor St. Luke's Medical Centre
    Houston, Texas, United States
    Recruiting
  • University of Utah Health
    Salt Lake City, Utah, United States
    Recruiting
  • Austral University Hospital
    Buenos Aires, Argentina
    Recruiting
  • Hospital Alemán
    Buenos Aires, Argentina
    Recruiting
  • Italian Hospital in Buenos Aires
    Buenos Aires, Argentina
    Recruiting
  • Austin Hospital
    Heidelberg, Australia
    Recruiting
  • Royal Prince Alfred Hospital
    Sydney, Australia
    Recruiting
  • Medical University of Vienna, Department of Transplant Surgery
    Vienna, Austria
    Recruiting
  • CUB Erasme Hospital
    Brussels, Belgium
    Recruiting
  • Ghent University Hospital
    Ghent, Belgium
    Recruiting
  • UZ Leuven
    Leuven, Belgium
    Recruiting
  • Walter Cantídio University Hospital
    Fortaleza, Brazil
    Recruiting
  • Irmandade Santa Casa de Misericórdia de Porto Alegre
    Porto Alegre, Brazil
    Recruiting
  • Hospital das Clínicas da Universidade de São Paulo
    São Paulo, Brazil
    Recruiting
  • University of Alberta
    Edmonton, Canada
    Recruiting
  • University of Toronto, Multiorgan Transplant Program
    Toronto, Canada
    Recruiting
  • Pablo Tobón Uribe Hospital
    Medellín, Colombia
    Recruiting
  • APHP Beaujon
    Clichy, France
    Recruiting
  • APHP Henri Mondor
    Créteil, France
    Recruiting
  • Hôpital de la Croix-Rousse
    Lyon, France
    Recruiting
  • CHU Montpellier-Hôpital Saint Eloi
    Montpellier, France
    Recruiting
  • APHP Hôpitaux Universitaires Pitié Salpêtrière
    Paris, France
    Recruiting
  • CHU Rennes, Hôpital De Pontchaillou
    Rennes, France
    Recruiting
  • Hautepièrre Hospital, Service de Réanimation Médicale
    Strasbourg, France
    Recruiting
  • Trousseau Hospital,
    Tours, France
    Recruiting
  • Hôpital Paul Brousse
    Villejuif, France
    Recruiting
  • Charité University Hospital
    Berlin, Germany
    Recruiting
  • University Medical Center, Hamburg Eppendorf
    Hamburg, Germany
    Recruiting
  • Universitätsklinikum Schleswig-Holstein (UKSH)
    Kiel, Germany
    Recruiting
  • UKM Muenster
    Münster, Germany
    Recruiting
  • University Hospital Tübingen
    Tübingen, Germany
    Recruiting
  • Dr.Rela Institute & Medical Centre
    Chennai, India
    Recruiting
  • Amrita Institute of Medical Sciences
    Kochi, India
    Recruiting
  • S.Orsola Hospital - Alma Mater Studiorum University of Bologna
    Bologna, Italy
    Recruiting
  • Ca' Granda. Policlinico Milano
    Milan, Italy
    Recruiting
  • Niguarda Hospital
    Milan, Italy
    Recruiting
  • University and Hospital of Padova
    Padova, Italy
    Recruiting
  • Kyushu University Hospital
    Fukuoka, Japan
    Recruiting
  • Hiroshima University Hospital
    Hiroshima, Japan
    Recruiting
  • Kyoto University Hospital
    Kyoto, Japan
    Recruiting
  • Nagasaki University Hospital
    Nagasaki, Japan
    Recruiting
  • Tokyo University Hospital
    Tokyo, Japan
    Recruiting

+56 more sites. See ClinicalTrials.gov for the full list.

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • CRISPR-edited donor liver transplant to reduce rejection

    This trial will try transplanting deceased-donor livers that have had key HLA genes removed with CRISPR to see if they cause less rejection in adults needing a liver transplant.

    Recruiting Phase 1/2 American Organ Transplant and Cancer Research Institute LLC · Beijing, Changping · NCT07053488

  • Identifying risk factors for complications after liver transplantation

    This study is trying to find out what factors can lead to bleeding and clotting problems after liver transplant surgery in patients with severe liver disease to help improve their recovery.

    Recruiting Republican Specialized Scientific and Practical Medical Center of Surgery Named After V. Vakhidov · Tashkent · NCT06169592

  • Registry for monitoring CytoSorb device use in critically ill patients

    This study is collecting information on how the CytoSorb device helps critically ill patients to improve care for conditions like septic shock and acute respiratory distress syndrome.

    Recruiting at 24 sites CytoSorbents, Inc · Klagenfurt and 27 other locations · NCT05146336

  • Predicting liver failure after surgery in patients with chronic liver disease

    This study is trying to find out what causes liver failure after surgery in people with chronic liver disease to help doctors better predict risks for their patients.

    Recruiting University Hospital, Bonn · Bonn · NCT04578301

  • Collection of clinical specimens for pediatric liver disease research

    This study is collecting samples from children with severe liver disease who are getting liver transplants to help improve our understanding and treatment of pediatric liver conditions in the future.

    Recruiting Children's Hospital of Chongqing Medical University · Chongqing, Chongqing Municipality · NCT04477967

  • Using spleen size to help detect gastroesophageal varices in compensated cirrhosis

    This study tests whether ultrasound measurements of spleen size can help identify esophageal varices in adults with compensated cirrhosis, compared with the standard endoscopy test.

    Recruiting Fifth Affiliated Hospital, Sun Yat-Sen University · Zhuhai, Guangdong · NCT07920744

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.